New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...

Health insurance costs are expected to rise in 2026, with patients potentially paying more for doctor visits and prescription coverage changes due to rising costs of care, prescription drugs, and new ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...

The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 ...

Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills ...

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...

Williams left the world of tennis behind back in 2022, when she played the final match of her career in the US Open, but she ...

Serena Williams revealed she has been taking a GLP-1 medication as part of her weight loss journey. In newly published ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a ...